Research summary, narrative review, 2019

Robotic-Assisted Percutaneous Coronary Intervention: Concept, Data, and Clinical Application

Walters D, Omran J, Patel M, Reeves R, Ang L, Mahmud E. Interventional cardiology clinics. 2019

Read the original paper

In plain language

This review describes robotic-assisted coronary intervention, which moves the interventional cardiologist away from the table, as a way to address occupational cataract, cancer and orthopedic risks. The abstract reports no measured dose reductions.

At a glance

Type of study
Narrative review
Who was studied
Interventional cardiologists
Summary based on
the abstract

What it found

  • Interventional cardiologists face occupational hazards including cataracts, malignancy and orthopedic injury.

  • The CorPath robotic system is approved for robotic-assisted cardiovascular interventions and removes the operator from the tableside.

  • The robotic system is described as validated for safety, feasibility and efficacy in coronary and peripheral vascular disease.

Limits to keep in mind

Narrative review summarized from an abstract only; no primary data or quantified dose or injury reductions are reported.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.